Literature DB >> 24503630

High resolution magic angle spinning NMR as a tool for unveiling the molecular enantiorecognition of omeprazole by amylose-based chiral phase.

Juliana Cristina Barreiro1, Tiago de Campos Lourenço, Lorena Mara A Silva, Tiago Venâncio, Quezia Bezerra Cass.   

Abstract

Polysaccharide-based chiral stationary phases (CSP) demonstrate great versatility and higher chiral selectivity for a variety of chiral compounds in multimodal elution modes (normal, reverse and polar organic). The main role of CSP phenyl carbamate based derivatives as chiral selectors is the formation of diastereoisomeric complexes by means of π-π interaction, dipole-dipole, hydrogen bonding and/or inclusion complex mechanisms. Nevertheless, the mechanism behind their enantioselectivity requires clarification. High resolution magic angle spinning nuclear magnetic resonance spectroscopy ((1)H HR/MAS NMR) has provided key information on the recognition process at the binding sites of the CSP surface. Herein we report the results obtained using omeprazole as a probe for these investigations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503630     DOI: 10.1039/c3an02029k

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  3 in total

1.  A High-Resolution Magic Angle Spinning NMR Study of the Enantiodiscrimination of 3,4-Methylenedioxymethamphetamine (MDMA) by an Immobilized Polysaccharide-Based Chiral Phase.

Authors:  Juliana C Barreiro; Márcio W Paixão; Tiago C Lourenço; Quezia B Cass; Tiago Venâncio
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

Review 2.  Enantiomeric Mixtures in Natural Product Chemistry: Separation and Absolute Configuration Assignment.

Authors:  Andrea N L Batista; Fernando M Dos Santos; João M Batista; Quezia B Cass
Journal:  Molecules       Date:  2018-02-23       Impact factor: 4.411

3.  Enantioseparation, Stereochemical Assignment and Chiral Recognition Mechanism of Sulfoxide-Containing Drugs.

Authors:  Fei Xiong; Bei-Bei Yang; Jie Zhang; Li Li
Journal:  Molecules       Date:  2018-10-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.